Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10294580" target="_blank" >RIV/00216208:11130/15:10294580 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/15:10294580
Result on the web
<a href="http://dx.doi.org/10.1007/s00467-014-2907-3" target="_blank" >http://dx.doi.org/10.1007/s00467-014-2907-3</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00467-014-2907-3" target="_blank" >10.1007/s00467-014-2907-3</a>
Alternative languages
Result language
angličtina
Original language name
Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units
Original language description
Few observations on apheresis in pediatric nephrology units have been published. This retrospective study involved children a parts per thousand currency sign18 years undergoing plasma exchange (PE), immunoadsorption (IA), or double filtration plasmapheresis (DFPP) in 12 European pediatric nephrology units during 2012. Sixty-seven children underwent PE, ten IA, and three DFPP, for a total of 738 PE and 349 IA/DFPP sessions; 67.2 % of PE and 69.2 % of IA/DFPP patients were treated for renal diseases, inparticular focal segmental glomerulosclerosis (FSGS), hemolytic-uremic syndrome (HUS), and human leukocyte antigen (HLA) desensitization prior to renal transplantation; 20.9 % of PE and 23.1 % of IA/DFPP patients had neurological diseases. Membrane filtration was the most common technique, albumin the most frequently used substitution fluid, and heparin the preferred anticoagulant. PE achieved full disease remission in 25 patients (37.3 %), partial remission in 22 (32.8 %), and had no ef
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FG - Paediatrics
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Pediatric Nephrology
ISSN
0931-041X
e-ISSN
—
Volume of the periodical
30
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
103-111
UT code for WoS article
000345411200011
EID of the result in the Scopus database
2-s2.0-84937511742